miR-499A>G rs3746444 and miR-146aG>C expression and hepatocellular carcinoma risk in the Chinese population

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 5365-5371

  Shan, Y F ^a   Huang, Y H ^a   Chen, Z K ^a   Huang, K T ^a   Zhou, M T ^a   Shi, H Q ^a   Song, Q T ^a   Yu, Z P ^a   Deng, A M ^b   Zhang, Q Y ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; miR 146aG>C rs2910164; miR 499A>G rs3746444; Susceptibility

Indexed keywords

ADENOSINE; CYTIDINE; GUANIDINE; MICRORNA; MICRORNA 146A; MICRORNA 499; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RNA ANALYSIS; RNA GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84887356255     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.November.7.11     Document Type: Article

References (27)

1. Akkiz H, Bayram S, Bekar A, Akgollu E, et al. (2011a). A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J. Viral Hepat. 18: e399-e407.
2. Akkiz H, Bayram S, Bekar A, Akgollu E, et al. (2011b). Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac. J. Cancer Prev. 12: 3107-3112.
3. Aumiller V and Forstemann K (2008). Roles of microRNAs beyond development-metabolism and neural plasticity. Biochim. Biophys. Acta 1779: 692-696.
4. Bhaumik D, Scott GK, Schokrpur S, Patil CK, et al. (2008). Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27: 5643-5647.
5. Catucci I, Yang R, Verderio P, Pizzamiglio S, et al. (2010). Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum. Mutat. 31: E1052-E1057.
6. Gao LB, Bai P, Pan XM, Jia J, et al. (2011). The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 125: 571-574.
7. He L and Hannon GJ (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5: 522-531.
8. Hu Z, Chen X, Zhao Y, Tian T, et al. (2010). Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol. 28: 1721-1726.
9. Hurst DR, Edmonds MD, Scott GK, Benz CC, et al. (2009). Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 69: 1279-1283.
10. International Agency for Research on Cancer (2008). Liver Cancer Incidence and Mortality Worldwide in 2008. Available at [http://globocan.iarc.fr/factsheets/cancers/liver.asp]. Accessed 2008.
11. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, et al. (2008). Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125-1129.
12. Krek A, Grun D, Poy MN, Wolf R, et al. (2005). Combinatorial microRNA target predictions. Nat. Genet. 37: 495-500.
13. Liu X, Zhang Z, Sun L, Chai N, et al. (2011). MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis 32: 1798-1805.
14. Lu X, Zhao P, Zhang C, Fu Z, et al. (2009). Analysis of miR-221 and p27 expression in human gliomas. Mol. Med. Rep. 2: 651-656.
15. Ludwig JA and Weinstein JN (2005). Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 5: 845-856.
16. Mocellin S, Pasquali S and Pilati P (2009). Oncomirs: from tumor biology to molecularly targeted anticancer strategies. Mini-Rev. Med. Chem. 9: 70-80.
17. Motsch N, Pfuhl T, Mrazek J, Barth S, et al. (2007). Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol. 4: 131-137.
18. Okubo M, Tahara T, Shibata T, Yamashita H, et al. (2010). Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 15: 524-531.
19. Pacifico F, Crescenzi E, Mellone S, Iannetti A, et al. (2010). Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a. J. Clin. Endocrinol. Metab. 95: 1421-1430.
20. Srivastava K and Srivastava A (2012). Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk. PLoS One 7: e50966.
21. Srivastava K, Srivastava A and Mittal B (2010). Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J. Hum. Genet. 55: 495-499.
22. Vinci S, Gelmini S, Pratesi N, Conti S, et al. (2011). Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin. Chem. Lab. Med. 49: 2073-2080.
23. Wang J, Bi J, Liu X, Li K, et al. (2012). Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies. Mol. Biol. Rep. 39: 4571-4579.
24. Xiang Y, Fan S, Cao J, Huang S, et al. (2012). Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol. Biol. Rep. 39: 7019-7023.
25. Xu T, Zhu Y, Wei QK, Yuan Y, et al. (2008). A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 29: 2126-2131.
26. Zhou B, Wang K, Wang Y, Xi M, et al. (2011). Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol. Carcinog. 50: 499-505.
27. Zhou M, Liu Z, Zhao Y, Ding Y, et al. (2010). MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J. Biol. Chem. 285: 21496-21507.